Ingrid Demedts
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ingrid Demedts has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Raf Bisschops
University Hospitals Leuven, KU Leuven, Belgium
6 shared publications - Philip Roelandt
University Hospital Leuven, Belgium
4 shared publications - Cesare Hassan
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20072 Milan, Italy
3 shared publications - Frederik Maes
KU Leuven
3 shared publications - Oliver Pech
Krankenhaus Barmherzige Brüder Regensburg, Regensburg, Germany
3 shared publications - Tom Eelbode
Department of Electrical Engineering (ESAT/PSI), Medical Imaging Research Center, KU Leuven, Leuven, Belgium
3 shared publications
Latest Publications
- Open Access
- 26 February 2024
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 10 (3) , e1593
Diagnosis and Management of Esophageal Fistulas After Lung Transplantation: A Case Series
Background. Lung transplantations are highly complex procedures, often conducted in frail patients. Through the addition of immunosuppressants, healing can be compromised, primarily leading to the development of bronchopleural fistulas. Although esophageal fistulas (EFs) after lung transplantation remain rare, they are associated with significant morbidity. We aimed to investigate the clinical presentation, diagnostic approaches, and treatment strategies of EF after lung transplantation. Methods. All patients who developed EF after lung transplantation at the University Hospitals Leuven between January 2019 and March 2022 were retrospectively reviewed and the clinical presentations, diagnostic approaches, and treatment strategies were summarized. Results. Among 212 lung transplantation patients, 5 patients (2.4%) developed EF. Three patients were male and median age was 39 y (range, 34–63). Intraoperative circulatory support was required in 3 patients, with 2 needing continued support postoperatively. Bipolar energy devices were consistently used for mediastinal hemostasis. All EFs were right-sided. Median time to diagnosis was 28 d (range, 12–48) and 80% of EFs presented as recurrent respiratory infections or empyema. Diagnosis was made through computed tomography (n = 3) or esophagogastroscopy (n = 2). Surgical repair with muscle flap covering achieved an 80% success rate. All patients achieved complete resolution, with only 1 patient experiencing a fatal outcome during a complicated EF-related recovery. Conclusion. Although EF after lung transplantation remains rare, vigilance is crucial, particularly in cases of right-sided intrathoracic infection. Moreover, caution must be exercised when applying thermal energy in the mediastinal area to prevent EF development and mitigate the risk of major morbidity. Timely diagnosis and surgical intervention can yield favorable outcomes. Export
- 26 February 2024
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 10 (3) , e1593
Open AccessDiagnosis and Management of Esophageal Fistulas After Lung Transplantation: A Case Series
Background. Lung transplantations are highly complex procedures, often conducted in frail patients. Through the addition of immunosuppressants, healing can be compromised, primarily leading to the development of bronchopleural fistulas. Although esophageal fistulas (EFs) after lung transplantation remain rare, they are associated with significant morbidity. We aimed to investigate the clinical presentation, diagnostic approaches, and treatment strategies of EF after lung transplantation. Methods. All patients who developed EF after lung transplantation at the University Hospitals Leuven between January 2019 and March 2022 were retrospectively reviewed and the clinical presentations, diagnostic approaches, and treatment strategies were summarized. Results. Among 212 lung transplantation patients, 5 patients (2.4%) developed EF. Three patients were male and median age was 39 y (range, 34–63). Intraoperative circulatory support was required in 3 patients, with 2 needing continued support postoperatively. Bipolar energy devices were consistently used for mediastinal hemostasis. All EFs were right-sided. Median time to diagnosis was 28 d (range, 12–48) and 80% of EFs presented as recurrent respiratory infections or empyema. Diagnosis was made through computed tomography (n = 3) or esophagogastroscopy (n = 2). Surgical repair with muscle flap covering achieved an 80% success rate. All patients achieved complete resolution, with only 1 patient experiencing a fatal outcome during a complicated EF-related recovery. Conclusion. Although EF after lung transplantation remains rare, vigilance is crucial, particularly in cases of right-sided intrathoracic infection. Moreover, caution must be exercised when applying thermal energy in the mediastinal area to prevent EF development and mitigate the risk of major morbidity. Timely diagnosis and surgical intervention can yield favorable outcomes. Export
- 3 September 2023
- Published by Elsevier in European Journal of Radiology
- Vol. 167, 111074
Factors influencing outcome of angiographic embolization for gastroduodenal hemorrhage related to peptic ulceration
- 3 September 2023
- Published by Elsevier in European Journal of Radiology
- Vol. 167, 111074
Factors influencing outcome of angiographic embolization for gastroduodenal hemorrhage related to peptic ulceration
- 10 July 2023
- Published by Elsevier in European Journal of Radiology
- Vol. 166, 110970
Factors influencing outcome of angiographic embolization for gastroduodenal hemorrhage related to peptic ulceration
- 10 July 2023
- Published by Elsevier in European Journal of Radiology
- Vol. 166, 110970
Factors influencing outcome of angiographic embolization for gastroduodenal hemorrhage related to peptic ulceration
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S10
Clinical validation of a computer-aided detection model for colorectal polyp detection (CAD-ARTIPOD) trial using a second observer and real-time unblinding
Aims This trial aimed to validate a CADe system for colorectal polyp detection versus trained endoscopists in an endoscopy blinded set-up with real-time unblinding. Methods The CAD-ARTIPOD trial is a prospective multicenter trial conducted in 9 European centers. CADe specifics were published earlier [1]. Sample size analysis for superiority required 2048 polyps assuming a difference in sensitivity of 2% with endoscopic diagnosis as gold standard. All endoscopists (ADR 20-50%) were blinded for the CADe output. A second observer classified in real time the CADe output in (1) true positive (detected/not detected by the endoscopist) (2) false negative or (3) clinically relevant or irrelevant false positive detection. If a polyp was only detected by CADe, the endoscopist was unblinded for confirmation of the finding. Histological assessment of endoscopically confirmed polyps was performed by two independent histopathologists. Results A number of 2080 polyps were collected, 1549 were histologically confirmed polyps. For the primary endpoint superiority was not reached between CADe and endoscopists (sensitivity (Sn) of 0.94 vs 0.96) (non-inferiority margin of 5%, p = 0.0216). False positive rate was 1.8/min. With histology as standard, CADe outperformed the endoscopists (Sn 0.96 versus 0.95 (p=0.03)) and showed an extra detection rate of 4.8% (Fig. [1]). Conclusions This manufacturer independent CADe system used in an innovative and competitive study design demonstrated non-inferiority in comparison to endoscopists’ polyp detection. However, with histology as gold standard CADe outperformed endoscopists. Our study also shows that “watching over a shoulder” in itself leads to higher PDR and ADR Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S10
Clinical validation of a computer-aided detection model for colorectal polyp detection (CAD-ARTIPOD) trial using a second observer and real-time unblinding
Aims This trial aimed to validate a CADe system for colorectal polyp detection versus trained endoscopists in an endoscopy blinded set-up with real-time unblinding. Methods The CAD-ARTIPOD trial is a prospective multicenter trial conducted in 9 European centers. CADe specifics were published earlier [1]. Sample size analysis for superiority required 2048 polyps assuming a difference in sensitivity of 2% with endoscopic diagnosis as gold standard. All endoscopists (ADR 20-50%) were blinded for the CADe output. A second observer classified in real time the CADe output in (1) true positive (detected/not detected by the endoscopist) (2) false negative or (3) clinically relevant or irrelevant false positive detection. If a polyp was only detected by CADe, the endoscopist was unblinded for confirmation of the finding. Histological assessment of endoscopically confirmed polyps was performed by two independent histopathologists. Results A number of 2080 polyps were collected, 1549 were histologically confirmed polyps. For the primary endpoint superiority was not reached between CADe and endoscopists (sensitivity (Sn) of 0.94 vs 0.96) (non-inferiority margin of 5%, p = 0.0216). False positive rate was 1.8/min. With histology as standard, CADe outperformed the endoscopists (Sn 0.96 versus 0.95 (p=0.03)) and showed an extra detection rate of 4.8% (Fig. [1]). Conclusions This manufacturer independent CADe system used in an innovative and competitive study design demonstrated non-inferiority in comparison to endoscopists’ polyp detection. However, with histology as gold standard CADe outperformed endoscopists. Our study also shows that “watching over a shoulder” in itself leads to higher PDR and ADR Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 19 March 2021
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 53 (S 01) , OP106
Endoscopic Mucosal Resection of Colorectal Polyps: Results, Adverse Events and Two-Year Outcome
Aims Endoscopic mucosal resection (EMR) is the first-line treatment for large sessile and flat colorectal polyps in Western centres. However, adenoma recurrence after EMR continues to be a challenge. The aim of this study is to assess the efficacy, safety and recurrence rate of EMR in a tertiary centre and to identify risk factors associated with local recurrence during first surveillance endoscopy (SE1). Methods We performed a retrospective study of 165 sessile and flat colorectal lesions measuring ≥15 mm, treated by EMR from October 2017 to October 2019. Colonoscopy and pathology reports were reviewed to identify recurrence. We used multivariate logistic regression to identify independent risk factors for recurrence at SE1. Results EMR was performed for 165 colorectal polyps in 142 patients and successful resection was achieved in 158 cases (95.2 %). SE1 data was available for 117 of 135 eligible cases (86.7 %) after a median time of 6.2 months (IQR 5-9.9), and showed recurrent adenoma in 19 cases (16.2 %). Recurrence was mainly treated endoscopically (78.9 %). Three patients (15.8 %) underwent surgery and one elected a conservative approach. Independent risk factors for recurrence at SE1 were lesion size ≥ 40 mm (odds ratio [OR] 4.03; p = 0.018) and presence of high-grade dysplasia (OR 3.89; p = 0.034). Early adverse event occurred in 4 patients (2.4 %) and consisted of 3 bleeding complications and 1 perforation. Twelve patients (7.2 %) presented with delayed bleeding of which 3 required transfusion, with radiological intervention in one case. All other complications were managed either conservatively (n = 8) or endoscopically (n = 5). Conclusions EMR is a safe and effective treatment for large sessile and flat colorectal lesions with low recurrence rates. Lesion size ≥ 40 mm and presence of HGD were identified as risk factors for early recurrence, highlighting the importance of compliance to follow-up in these cases. Citation: Chaoui I, Demedts I, Roelandt P et al. OP106 ENDOSCOPIC MUCOSAL RESECTION OF COLORECTAL POLYPS: RESULTS, ADVERSE EVENTS AND TWO-YEAR OUTCOME. Endoscopy 2021; 53: S45. Publication Date: 19 March 2021 (online) © 2021. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 19 March 2021
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 53 (S 01) , OP106
Open AccessEndoscopic Mucosal Resection of Colorectal Polyps: Results, Adverse Events and Two-Year Outcome
Aims Endoscopic mucosal resection (EMR) is the first-line treatment for large sessile and flat colorectal polyps in Western centres. However, adenoma recurrence after EMR continues to be a challenge. The aim of this study is to assess the efficacy, safety and recurrence rate of EMR in a tertiary centre and to identify risk factors associated with local recurrence during first surveillance endoscopy (SE1). Methods We performed a retrospective study of 165 sessile and flat colorectal lesions measuring ≥15 mm, treated by EMR from October 2017 to October 2019. Colonoscopy and pathology reports were reviewed to identify recurrence. We used multivariate logistic regression to identify independent risk factors for recurrence at SE1. Results EMR was performed for 165 colorectal polyps in 142 patients and successful resection was achieved in 158 cases (95.2 %). SE1 data was available for 117 of 135 eligible cases (86.7 %) after a median time of 6.2 months (IQR 5-9.9), and showed recurrent adenoma in 19 cases (16.2 %). Recurrence was mainly treated endoscopically (78.9 %). Three patients (15.8 %) underwent surgery and one elected a conservative approach. Independent risk factors for recurrence at SE1 were lesion size ≥ 40 mm (odds ratio [OR] 4.03; p = 0.018) and presence of high-grade dysplasia (OR 3.89; p = 0.034). Early adverse event occurred in 4 patients (2.4 %) and consisted of 3 bleeding complications and 1 perforation. Twelve patients (7.2 %) presented with delayed bleeding of which 3 required transfusion, with radiological intervention in one case. All other complications were managed either conservatively (n = 8) or endoscopically (n = 5). Conclusions EMR is a safe and effective treatment for large sessile and flat colorectal lesions with low recurrence rates. Lesion size ≥ 40 mm and presence of HGD were identified as risk factors for early recurrence, highlighting the importance of compliance to follow-up in these cases. Citation: Chaoui I, Demedts I, Roelandt P et al. OP106 ENDOSCOPIC MUCOSAL RESECTION OF COLORECTAL POLYPS: RESULTS, ADVERSE EVENTS AND TWO-YEAR OUTCOME. Endoscopy 2021; 53: S45. Publication Date: 19 March 2021 (online) © 2021. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 23 April 2020
- Published by Georg Thieme Verlag KG
- Vol. 52 (S 01) , OP61
A PROSPECTIVE, MULTI-CENTER VALIDATION STUDY FOR AUTOMATED POLYP DETECTION AS A SECOND OBSERVER
Aims Last year, we presented a deep learning framework for automated polyp detection. Contrary to classical CNNs, we use ‘memory cells’ enabling more accurate predictions. Little evidence is available on the performance of AI for polyp detection in clinical practice. The aim of this study is to prospectively validate our system in a multi-center clinical setting to obtain an estimate power calculation for future trial design and to assess preliminary performance compared to experienced endoscopists. Methods Our system was trained with 131.619 frames from 825 polyps from 206 patients and was implemented in a bedside module for real-time analysis. In this study, an experienced endoscopist (ADR>35%) does not see the system output while a second observer looks at the AI-enhanced screen. We define four different situations: (1) Obvious false positive - the system gives an obviously false detection (stool, air bubbles, …). (2) Other positive - after its location disappears from the image, the endoscopist is asked to return. If there is a polyp, this is an additional detection. (3) False negative - the endoscopist found a polyp, but the system didn’t. (4) True positive - the system and endoscopist found the polyp. Results Currently, 99/300 patients are included from three European centers. In total 199 polyps were found of which 181 were detected by the system and endoscopist. There were 13 false negatives (all diminutive) and 5 additional detections by the system. Combined, this corresponds to a 3% increase in polyps-per-colonoscopy. A low average of 1 false positive per minute was recorded. Conclusions The interim analysis shows promising results for the clinical validation of a novel AI system. These exploratory studies are important to power future trials and to estimate the optimal trial design (non-inferiority versus superiority). We plan to include 300 patients by the ESGE days 2020 and present the full results.
- 23 April 2020
- Published by Georg Thieme Verlag KG
- Vol. 52 (S 01) , OP61
A PROSPECTIVE, MULTI-CENTER VALIDATION STUDY FOR AUTOMATED POLYP DETECTION AS A SECOND OBSERVER
Aims Last year, we presented a deep learning framework for automated polyp detection. Contrary to classical CNNs, we use ‘memory cells’ enabling more accurate predictions. Little evidence is available on the performance of AI for polyp detection in clinical practice. The aim of this study is to prospectively validate our system in a multi-center clinical setting to obtain an estimate power calculation for future trial design and to assess preliminary performance compared to experienced endoscopists. Methods Our system was trained with 131.619 frames from 825 polyps from 206 patients and was implemented in a bedside module for real-time analysis. In this study, an experienced endoscopist (ADR>35%) does not see the system output while a second observer looks at the AI-enhanced screen. We define four different situations: (1) Obvious false positive - the system gives an obviously false detection (stool, air bubbles, …). (2) Other positive - after its location disappears from the image, the endoscopist is asked to return. If there is a polyp, this is an additional detection. (3) False negative - the endoscopist found a polyp, but the system didn’t. (4) True positive - the system and endoscopist found the polyp. Results Currently, 99/300 patients are included from three European centers. In total 199 polyps were found of which 181 were detected by the system and endoscopist. There were 13 false negatives (all diminutive) and 5 additional detections by the system. Combined, this corresponds to a 3% increase in polyps-per-colonoscopy. A low average of 1 false positive per minute was recorded. Conclusions The interim analysis shows promising results for the clinical validation of a novel AI system. These exploratory studies are important to power future trials and to estimate the optimal trial design (non-inferiority versus superiority). We plan to include 300 patients by the ESGE days 2020 and present the full results.
- 1 June 2019
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 89 (6) , AB618-AB619
Tu1931 INCORPORATION OF TEMPORAL INFORMATION IN A DEEP NEURAL NETWORK IMPROVES PERFORMANCE LEVEL FOR AUTOMATED POLYP DETECTION AND DELINEATION
- 1 June 2019
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 89 (6) , AB618-AB619
Tu1931 INCORPORATION OF TEMPORAL INFORMATION IN A DEEP NEURAL NETWORK IMPROVES PERFORMANCE LEVEL FOR AUTOMATED POLYP DETECTION AND DELINEATION
- Open Access
- 14 August 2018
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 50 (11) , E318-E319
Treatment of low grade dysplasia in Barrett’s esophagus with a new-generation cryoballoon device
A 53-year-old man with Barrett’s esophagus (BE; C1M4), who was under regular surveillance, developed multifocal low grade dysplasia (LGD) without visible lesions ([Fig. 1 a]). The diagnosis of LGD was confirmed by a second expert pathologist. As radiofrequency ablation for LGD is not reimbursed in our country, and given the previous experience with cryotherapy, we decided to treat the patient with cryoablation (C2-CryoBalloon Focal Ablation System; C2 Therapeutics, Redwood City, California, USA) ([Video 1]). Video 1 Cryotherapy with the novel cryoballoon system to treat Barrett’s esophagus with low grade dysplasia. Cryotherapy can successfully eradicate neoplastic BE by inducing extreme cold to tissue, which causes cell necrosis of the superficial esophageal layers [1]. CryoBalloon is a device that has been developed to deliver cryotherapy, with a single spray hole in the shaft covered by a compliant balloon [2] [3]. The device was recently adapted to include a foot pedal control, allowing the endoscopist to self-control the axial and radial position of the diffuser head and the application of nitrous oxide. The addition of axial control avoids the need to reposition the balloon. The cryoballoon catheter was introduced through the working channel, and the circular component of BE was treated in a 4-quadrant fashion, using the radial control, followed by axial adjustments to ablate the upper segments of BE ([Fig. 1 b]). The technique was repeated until complete cryoablation of BE had been achieved ([Fig. 1 c]). The treatment lasted for 15 minutes. Two weeks later, the patient developed severe thoracic pain and heartburn. Endoscopy revealed grade D esophagitis and no other complications. Symptoms resolved after optimization of anti-acid therapy. At the 3-month follow-up endoscopy, complete regeneration of BE to neosquamous epithelium was observed, with mild inflammation of the Z-line ([Fig. 1 d]). Biopsies confirmed no intestinal metaplasia or dysplasia. This case demonstrates the use of a new-generation cryoballoon system for treatment of dysplastic BE. The treatment was effective and was facilitated by the axial movement of the diffuser, achieving full eradication of dysplastic BE in a single session. Endoscopy_UCTN_Code_TTT_1AO_2AF
- 14 August 2018
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 50 (11) , E318-E319
Open AccessTreatment of low grade dysplasia in Barrett’s esophagus with a new-generation cryoballoon device
A 53-year-old man with Barrett’s esophagus (BE; C1M4), who was under regular surveillance, developed multifocal low grade dysplasia (LGD) without visible lesions ([Fig. 1 a]). The diagnosis of LGD was confirmed by a second expert pathologist. As radiofrequency ablation for LGD is not reimbursed in our country, and given the previous experience with cryotherapy, we decided to treat the patient with cryoablation (C2-CryoBalloon Focal Ablation System; C2 Therapeutics, Redwood City, California, USA) ([Video 1]). Video 1 Cryotherapy with the novel cryoballoon system to treat Barrett’s esophagus with low grade dysplasia. Cryotherapy can successfully eradicate neoplastic BE by inducing extreme cold to tissue, which causes cell necrosis of the superficial esophageal layers [1]. CryoBalloon is a device that has been developed to deliver cryotherapy, with a single spray hole in the shaft covered by a compliant balloon [2] [3]. The device was recently adapted to include a foot pedal control, allowing the endoscopist to self-control the axial and radial position of the diffuser head and the application of nitrous oxide. The addition of axial control avoids the need to reposition the balloon. The cryoballoon catheter was introduced through the working channel, and the circular component of BE was treated in a 4-quadrant fashion, using the radial control, followed by axial adjustments to ablate the upper segments of BE ([Fig. 1 b]). The technique was repeated until complete cryoablation of BE had been achieved ([Fig. 1 c]). The treatment lasted for 15 minutes. Two weeks later, the patient developed severe thoracic pain and heartburn. Endoscopy revealed grade D esophagitis and no other complications. Symptoms resolved after optimization of anti-acid therapy. At the 3-month follow-up endoscopy, complete regeneration of BE to neosquamous epithelium was observed, with mild inflammation of the Z-line ([Fig. 1 d]). Biopsies confirmed no intestinal metaplasia or dysplasia. This case demonstrates the use of a new-generation cryoballoon system for treatment of dysplastic BE. The treatment was effective and was facilitated by the axial movement of the diffuser, achieving full eradication of dysplastic BE in a single session. Endoscopy_UCTN_Code_TTT_1AO_2AF
- 1 May 2017
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 85 (5) , AB541
Tu1017 Pilot Results of the ECQI Self-Assessment Questionnaire to Evaluate Quality in Colonoscopy in Europe
- 1 May 2017
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 85 (5) , AB541
Tu1017 Pilot Results of the ECQI Self-Assessment Questionnaire to Evaluate Quality in Colonoscopy in Europe
- 14 November 2006
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 18 (12) , 1102-1111
Neural mechanisms of early postinflammatory dysmotility in rat small intestine
Abstract Although human postinflammatory dysmotility is known, so far animal studies have primarily investigated changes during inflammation. Here, we focused on postinflammatory changes in rat jejunal myenteric plexus and jejunal motility. Evolution of ethanol/2,4,6‐tri‐nitrobenzene sulphonic acid (TNBS)‐induced inflammation was assessed histologically and by measuring myeloperoxidase activity (MPO). Electromyography and immunohistochemistry were performed 1 week after ethanol/TNBS and also after NG‐nitro‐l‐arginine methyl ester (l‐NAME) administration. Ethanol/TNBS induced a transient inflammation, with normalization of MPO and histological signs of an early phase of recovery after 1 week. The number of cholinergic neurones was not altered, but myenteric neuronal nitric oxide synthase (nNOS)‐immunoreactivity was significantly lower in the early phase of recovery after TNBS compared with water (1.8 ± 0.2vs3.5 ± 0.2 neurones ganglion−1,P < 0.001). Interdigestive motility was disrupted with a loss of phase 1 quiescence, an increase of migrating myoelectric complex cycle length, a higher number of non‐propagated activity fronts and a decrease of adequately propagated phase 3 s after TNBS. Administration ofl‐NAME resulted in a similar disruption of interdigestive motility patterns. In the early phase of recovery after ethanol/TNBS‐induced jejunal inflammation, a loss of motor inhibition occurs due to a decrease of myenteric nNOS activity. These observations may provide a model for early postinflammatory dysmotility syndromes.
- 14 November 2006
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 18 (12) , 1102-1111
Neural mechanisms of early postinflammatory dysmotility in rat small intestine
Abstract Although human postinflammatory dysmotility is known, so far animal studies have primarily investigated changes during inflammation. Here, we focused on postinflammatory changes in rat jejunal myenteric plexus and jejunal motility. Evolution of ethanol/2,4,6‐tri‐nitrobenzene sulphonic acid (TNBS)‐induced inflammation was assessed histologically and by measuring myeloperoxidase activity (MPO). Electromyography and immunohistochemistry were performed 1 week after ethanol/TNBS and also after NG‐nitro‐l‐arginine methyl ester (l‐NAME) administration. Ethanol/TNBS induced a transient inflammation, with normalization of MPO and histological signs of an early phase of recovery after 1 week. The number of cholinergic neurones was not altered, but myenteric neuronal nitric oxide synthase (nNOS)‐immunoreactivity was significantly lower in the early phase of recovery after TNBS compared with water (1.8 ± 0.2vs3.5 ± 0.2 neurones ganglion−1,P < 0.001). Interdigestive motility was disrupted with a loss of phase 1 quiescence, an increase of migrating myoelectric complex cycle length, a higher number of non‐propagated activity fronts and a decrease of adequately propagated phase 3 s after TNBS. Administration ofl‐NAME resulted in a similar disruption of interdigestive motility patterns. In the early phase of recovery after ethanol/TNBS‐induced jejunal inflammation, a loss of motor inhibition occurs due to a decrease of myenteric nNOS activity. These observations may provide a model for early postinflammatory dysmotility syndromes.